Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yisaipu and Tripterygium Wilfordii in Active Rheumatoid Arthritis
NCT03589833Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept, Tripterygium wilfordii in rheumatoid arthritis (RA), sponsored by Peking Union Medical College Hospital. Started May 2019; status: completed.
02
Drugs
etanerceptTripterygium wilfordii
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03589833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03589833.